{"disease":{"id":"cold-urticaria","name":"cold urticaria"},"drugs":{"marketed":[],"pipeline":[],"offLabel":[],"totalMarketed":0,"totalPipeline":0},"trials":{"data":[{"nct_id":"NCT04681729","title":"Dupilumab for the Treatment of Chronic Inducible Cold Urticaria in Patients Who Remain Symptomatic Despite the Use of H1-antihistamine (LIBERTY-CINDU CUrIADS)","phase":"PHASE3","overall_status":"COMPLETED","enrollment_count":82,"lead_sponsor_name":"Sanofi","has_results":true},{"nct_id":"NCT04548869","title":"A Single Dose Study of the Safety, Pharmacokinetics and Pharmacodynamics of CDX-0159 in Patients With Cold Contact Urticaria, Symptomatic Dermographism, or Cholinergic Urticaria","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":41,"lead_sponsor_name":"Celldex Therapeutics","has_results":false},{"nct_id":"NCT06544018","title":"Circadian Rhythm Deregulation in Patients With CAPS","phase":"NA","overall_status":"RECRUITING","enrollment_count":30,"lead_sponsor_name":"Hospices Civils de Lyon","has_results":false},{"nct_id":"NCT05960708","title":"A Single Dose, Phase 1 Study of YH35324 in Patients with Various Allergic Diseases","phase":"PHASE1","overall_status":"COMPLETED","enrollment_count":30,"lead_sponsor_name":"Yuhan Corporation","has_results":false},{"nct_id":"NCT04513548","title":"Study of Mechanism of Action of Ligelizumab (QGE031) in Patients With Chronic Urticaria","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":11,"lead_sponsor_name":"Novartis Pharmaceuticals","has_results":false},{"nct_id":"NCT05510843","title":"A Study to Evaluate THB001 in Adult Patients With Chronic Cold Urticaria","phase":"PHASE1","overall_status":"TERMINATED","enrollment_count":5,"lead_sponsor_name":"Third Harmonic Bio, Inc.","has_results":false}],"total":6},"guidelines":[],"source":"Drug Landscape verified database"}